Cargando…
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
The glycolytic PFKFB3 enzyme is widely overexpressed in cancer cells and an emerging anti-cancer target. Here, we identify PFKFB3 as a critical factor in homologous recombination (HR) repair of DNA double-strand breaks. PFKFB3 rapidly relocates into ionizing radiation (IR)-induced nuclear foci in an...
Autores principales: | Gustafsson, Nina M. S., Färnegårdh, Katarina, Bonagas, Nadilly, Ninou, Anna Huguet, Groth, Petra, Wiita, Elisee, Jönsson, Mattias, Hallberg, Kenth, Lehto, Jemina, Pennisi, Rosa, Martinsson, Jessica, Norström, Carina, Hollers, Jessica, Schultz, Johan, Andersson, Martin, Markova, Natalia, Marttila, Petra, Kim, Baek, Norin, Martin, Olin, Thomas, Helleday, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155239/ https://www.ncbi.nlm.nih.gov/pubmed/30250201 http://dx.doi.org/10.1038/s41467-018-06287-x |
Ejemplares similares
-
PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair
por: Ninou, Anna Huguet, et al.
Publicado: (2021) -
Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum
por: Lehto, Jemina, et al.
Publicado: (2021) -
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells
por: Green, Alanna C., et al.
Publicado: (2023) -
The First Structure of Human MTHFD2L and Its Implications for the Development of Isoform‐Selective Inhibitors
por: Scaletti, Emma R., et al.
Publicado: (2022) -
In silico Druggability Assessment of the NUDIX Hydrolase Protein Family as a Workflow for Target Prioritization
por: Michel, Maurice, et al.
Publicado: (2020)